Kaposi's Sarcoma in Renal Allograft Recipients
Authors
Affiliations
The development of Kaposi's sarcoma in immunosuppressed patients is a rare occurrence, but poses a real threat to the patient due to the rapid progression of the unchecked disease. The suspicion of this disease will prompt early diagnosis by scrutiny of histologic preparations and prompt interruption of antirejection therapy. Four of five patients in whom a diagnosis was made preterminally responded favorably to withdrawal of immunosuppressive agents. In renal allograft recipients with mucocutaneous vascular lesions, Kaposi's sarcoma should be considered as a cause of gastrointestinal bleeding.
[Kaposi sarcoma-a complication of treatment refractory ulcerative colitis].
Fischer A, Kroesen A, Buttner R, Drebber U Pathologie (Heidelb). 2022; 43(5):372-376.
PMID: 35925309 PMC: 9402725. DOI: 10.1007/s00292-022-01090-4.
Mansfield S, Stawicki S, Forbes R, Papadimos T, Lindsey D J Gastrointestin Liver Dis. 2013; 22(4):441-5.
PMID: 24369327 PMC: 4097021.
Ruocco E, Ruocco V, Tornesello M, Gambardella A, Wolf R, Buonaguro F Clin Dermatol. 2013; 31(4):413-422.
PMID: 23806158 PMC: 7173141. DOI: 10.1016/j.clindermatol.2013.01.008.
Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran.
Jalilvand S, Shoja Z, Mokhtari-Azad T, Nategh R, Gharehbaghian A Infect Agent Cancer. 2011; 6:5.
PMID: 21527020 PMC: 3108908. DOI: 10.1186/1750-9378-6-5.
Sullivan R, Pantanowitz L, Casper C, Stebbing J, Dezube B Clin Infect Dis. 2008; 47(9):1209-15.
PMID: 18808357 PMC: 2700291. DOI: 10.1086/592298.